Use access key #2 to skip to page content.
$9.94 -0.08 (-0.80%)
10/10/2008 4:00 PM

Alkermes, Inc. (ALKS)

CAPS Rating:
****

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.

View All Commentary (ALKS)

Recs

0

Avatar lulamae12 (< 20) Submitted: 6/08/08 8:27 PM : Outperform Start Price: $12.64 ALKS Score: 14.07

ALKS, a name you will be hearing due to the development of several new drugs. ALKS is currently working with its partner, Johnson and Johnson, in the development of a drug to to treat rapidly recurring Bi-Polar disorder. Alks has also developed a drug to treat pulmonary obstructive disease. The other drug that is showing great strides is one that is taken only once a week for diabetes control. Most of the drugs currently used for this are injectable at least once a day if not more. This compares to the ALKS drug that is inhaled. People with diabetes would be ecstatic to see this drug on the market.
A restructuring program has been initiated at ALKS. That with the new drugs mean BUY NOW! .......before the price goes up.

Report this Post Replies: 0 | Reply

Featured Broker Partners